| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Alexion Pharmaceuticals, New Haven, CT 06511
Recent studies have suggested that soluble forms of B7-1 and B7-2 may exist, but transcripts that code for these molecules have not been previously described. In this study, we report the cloning and characterization of an alternatively spliced soluble form of porcine B7-1 (sB7-1) that lacks exons coding for both the transmembrane and cytoplasmic domains. Northern blot analysis of RNA from alveolar macrophages revealed an approximate 3:1 ratio of the transmembrane form of B7-1 mRNA relative to sB7-1 mRNA. Porcine B7-1 was present on the surface of both B and T cells following stimulation with PMA/ionomycin. A histidine-tagged form of porcine sB7-1 (sB7-1-His) interacted with both CD28 and CTLA-4, and effectively blocked IL-2 production from human responder cells stimulated with PHA and either porcine or human stimulator cells. In addition, sB7–1-His inhibited human T cell proliferation in response to porcine or human peripheral blood leukocytes. This study is the first report of an alternatively spliced form of B7 that codes for a soluble protein. Furthermore, these data demonstrate that porcine B7-1 interacts with the human receptors CD28 and CTLA-4, suggesting a potential role for this molecule in pig to human xenotransplantation. Possible physiological functions for the soluble form of B7-1 are discussed.
This article has been cited by other articles:
|
|
 |
|
  D. Homann, W. Dummer, T. Wolfe, E. Rodrigo, A. N. Theofilopoulos, M. B. A. Oldstone, and M. G. von Herrath Lack of Intrinsic CTLA-4 Expression Has Minimal Effect on Regulation of Antiviral T-Cell Immunity J. Virol., January 1, 2006; 80(1): 270 - 280. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 I.-H. Choi, G. Zhu, G. L. Sica, S. E. Strome, J. C. Cheville, J. S. Lau, Y. Zhu, D. B. Flies, K. Tamada, and L. Chen Genomic Organization and Expression Analysis of B7-H4, an Immune Inhibitory Molecule of the B7 Family J. Immunol., November 1, 2003; 171(9): 4650 - 4654. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S.-C. Wong, E. Oh, C.-H. Ng, and K.-P. Lam Impaired germinal center formation and recall T-cell-dependent immune responses in mice lacking the costimulatory ligand B7-H2 Blood, August 15, 2003; 102(4): 1381 - 1388. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Lahat, M. A. Rahat, M. Ballan, L. Weiss-Cerem, M. Engelmayer, and H. Bitterman Hypoxia reduces CD80 expression on monocytes but enhances their LPS-stimulated TNF-{alpha} secretion J. Leukoc. Biol., August 1, 2003; 74(2): 197 - 205. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 V. Douin-Echinard, J.-M. Peron, V. Lauwers-Cances, G. Favre, and B. Couderc Involvement of CD70 and CD80 intracytoplasmic domains in the co-stimulatory signal required to provide an antitumor immune response Int. Immunol., March 1, 2003; 15(3): 359 - 372. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Costa, D. F. Barber, and W. L. Fodor Human NK Cell-Mediated Cytotoxicity Triggered by CD86 and Gal{alpha}1,3-Gal Is Inhibited in Genetically Modified Porcine Cells J. Immunol., April 15, 2002; 168(8): 3808 - 3816. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. Ling, P. W. Wu, J. S. Miyashiro, S. Marusic, H. F. Finnerty, and M. Collins Differential Expression of Inducible Costimulator-Ligand Splice Variants: Lymphoid Regulation of Mouse GL50-B and Human GL50 Molecules J. Immunol., June 15, 2001; 166(12): 7300 - 7308. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. K. Kapsogeorgou, H. M. Moutsopoulos, and M. N. Manoussakis Functional Expression of a Costimulatory B7.2 (CD86) Protein on Human Salivary Gland Epithelial Cells that Interacts with the CD28 Receptor, but Has Reduced Binding to CTLA4 J. Immunol., March 1, 2001; 166(5): 3107 - 3113. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
